GlassScriptPhysician profile
Melissa Litwin
NPI 1851998553
$2,935.39
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,122 · 2023: $1,696 · 2024: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $456.43 | 2022-2023 | Mounjaro, Trulicity, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $353.32 | 2022-2023 | Trulance, Xifaxan |
| Novo Nordisk INC | $285.87 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $281.07 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.30 | 2022-2023 | Jardiance |
| Pfizer INC. | $207.77 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $134.09 | 2022-2023 | Farxiga |
| Axonics, INC. | $117.14 | 2024 | Axonics |
| Teva Pharmaceuticals USA, INC. | $103.46 | 2022-2023 | Proair Digihaler |
| Janssen Pharmaceuticals, INC | $99.32 | 2022-2023 | Xarelto |
| Xeris Pharmaceuticals, INC. | $88.64 | 2022-2023 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $77.64 | 2023 | Eliquis |
| Glaxosmithkline, LLC. | $74.05 | 2023 | Shingrix, Arexvy |
| Abbvie INC. | $49.53 | 2023 | |
| Exact Sciences Corporation | $49.31 | 2023 | Cologuard Collection Kit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $38.59 | 2022-2023 | Immunocap |
| Astellas Pharma US INC | $38.58 | 2023 | Veozah |
| Intuity Medical INC | $32.97 | 2022 | |
| Azurity Pharmaceuticals, INC. | $31.26 | 2023 | Edarbi |
| Kowa Pharmaceuticals America, INC. | $30.31 | 2023 | Seglentis, Livalo |
| Avanos Medical | $24.90 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Renalytix Ai, INC. | $24.16 | 2022 | |
| Dexcom, INC. | $23.79 | 2022 | |
| Cequr Corporation | $22.61 | 2023 | Cequr Simplicity |
| Mylan Specialty L.P. | $18.57 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Litwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.